Stock Analysis: Biogen Inc (BIIB)

Stock Analysis for Biogen Inc (BIIB)

The Interpreter
Hey Friend, I'm analysing BIOGEN INC (BIIB), and it is between the Support of $ 197.81 (150% of Fibonacci) and the Resistance of $ 198.80 (PivotS1). The stock is falling and may come close and reach $ 197.81 soon.

Biogen Inc (BIIB)

$ 190.52 -0.9%

Last Close 18-Apr-24

Trade BIIB Now

Supports

Next Support: $ 197.81

Pivot S2: $ 193.74
Fibonacci 150%: $ 197.81

Resistances

Next Resistance: $ 198.80

Pivot S1: $ 198.80
Fibonacci 138.2%: $ 202.03
Triangle Level (0): $ 202.43

Supports and Resistances

Click to Enlarge

Candlesticks, "48-hour" Trade Signals +

Date	Price $	Result %	Candle Name	Side
001 22 Mar 2024	Buy Price: 218.28	Loss: Close Day2 ($ 212.02)	Abandoned Baby	Buy
002 22 Mar 2024	Sell Price: 218.10	Profit: Open Day1 ($ 217.77)	Engulfing	Sell
003 21 Mar 2024	Buy Price: 220.75	Profit: Open Day1 ($ 221.30)	Abandoned Baby	Buy
004 18 Mar 2024	Buy Price: 219.40	Loss: Close Day2 ($ 218.15)	Abandoned Baby	Buy
005 07 Feb 2024	Sell Price: 240.54	Profit: Open Day1 ($ 239.89)	Engulfing	Sell
006 06 Feb 2024	Buy Price: 245.55	Profit: Open Day1 ($ 246.44)	Engulfing	Buy
007 31 Jan 2024	Sell Price: 246.66	Profit: Open Day1 ($ 245.40)	Dark Cloud Cover	Sell
008 29 Jan 2024	Buy Price: 247.52	Profit: Open Day2 ($ 247.67)	Engulfing	Buy
009 29 Jan 2024	Buy Price: 247.26	Profit: Open Day2 ($ 247.67)	Piercing Line	Buy
010 02 Jan 2024	Buy Price: 267.71	Profit: Open Day1 ($ 268.27)	Engulfing	Buy
011 28 Dec 2023	Sell Price: 260.49	Profit: Open Day1 ($ 260.16)	Abandoned Baby	Sell
012 28 Dec 2023	Sell Price: 260.58	Profit: Open Day1 ($ 260.16)	Engulfing	Sell
013 14 Nov 2023	Buy Price: 225.26	Profit: Close Day1 ($ 229.63)	Abandoned Baby	Buy
014 04 Oct 2023	Buy Price: 257.16	Profit: Open Day1 ($ 258.00)	Abandoned Baby	Buy
015 06 Jul 2023	Sell Price: 284.99	Profit: Close Day1 ($ 275.07)	Engulfing	Sell
016 07 Jun 2023	Buy Price: 304.90	Profit: Open Day1 ($ 310.69)	Engulfing	Buy
017One Year Average	Both Sides Result for 16 Signals	Profit: $ 18.96 ($ 1.19 / Signal) +7.7% Gross in 1 Year	All of Them	Buy + Sell

Trading Rules for Candlesticks Patterns.

Buy or Sell on the same day of the signal, during the after-hours trading session.
Watch the Opening and Closing of the next 2 days (4 in total).
Immediately exit the Trade when one of them (Open or Close, Day 1 or 2) gives you a profit.
The table above will show the first Profit opportunity, but not in real-time. Therefore, you must watch the market in real-time with your broker.

Remember: The returns an asset made in the past don't mean that future returns will be the same.

Backtest Lab, "Buy The Dip" Trade Signals +

Find The Lastest Buy Signals for BIIB Below.

Please Subscribe to See
The Latest Trade Signals

Moving Averages +

Bought Moving Averages

Sold Moving Averages

Simple Moving Averages (SMA) Period	Value $	Signal	Exponential Moving Averages (EMA) Period	Value $	Signal
2	191.34	SELL	2	191.50	SELL
3	192.61	SELL	3	192.55	SELL
5	194.56	SELL	5	194.53	SELL
8	198.07	SELL	8	197.10	SELL
13	200.98	SELL	13	200.63	SELL
21	206.91	SELL	21	205.08	SELL
34	212.52	SELL	34	210.72	SELL
55	219.64	SELL	55	217.64	SELL
90	232.36	SELL	90	225.89	SELL
200	245.76	SELL	200	241.09	SELL

Company Info +

Name & IPO

Biogen Inc
IPO: 1991-09-17

Stock Ticker & Exchange

Ticker: BIIBIndices: S&P 500, Nasdaq 100,
Exchange: Nasdaq Nms - Global Market (US - USD)

Contact

Website: https://www.biogen.com/
Phone:

Stock Type

Common Stock

SIC Office

Life Sciences ()

Industry

Biological Products, (no Disgnostic Substances)

EIN

Fiscal Year End

State of Inc.

Balance Sheets +

in USD millions (if not decimal) - Dictionary

Income Statement +

in USD millions (if not decimal) - Dictionary

Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.